I agree that this site is using cookies. You can find further informations here.
X
Jindra, P.
118  results:
Search for persons X
?
1

P613 Beware of false negative virtual crossmatches in a cul..:

Shin, H. ; Woolley, N. ; Chitnis, N...
Human Immunology.  84 (2023)  - p. 169 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Immunotherapy: INVARIANT NKT CELLS CULTURED IN IL2 OR IL15 ..:

Holubova, M. ; Dekojova, T. ; Rechtorikova, R....
Cytotherapy.  25 (2023)  6 - p. S228-S229 , 2023
Link: https://doi.org/10.1016/..
 
?
3

O37 HLA-L pseudogene as a potential microRNA sponge for reg..:

Chitnis, N. ; Shin, H. ; Utt, K....
Human Immunology.  84 (2023)  - p. 54 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Sequential vs myeloablative vs reduced intensity conditioni..:

Potter, V. ; Gras, L. ; Koster, L....
Bone Marrow Transplantation.  59 (2023)  2 - p. 224-231 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Differences in the characteristics and functions of invaria..:

Dostalova, K. ; Jindra, P. ; Lysak, D..
Cytotherapy.  23 (2021)  5 - p. S91-S93 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Intra-operative kinetics of anti-HLA antibody in simultaneo..:

Kueht, M. ; Jindra, P. ; Stevenson, H.L....
Molecular Genetics and Metabolism Reports.  26 (2021)  - p. 100705 , 2021
Link: https://doi.org/10.1016/..
 
?
7

MULTICENTER RETROSPECTIVE ANALYSIS OF RISK FACTORS FOR MORT..:

Kořen, J. ; Steinerová, K. ; Janíková, A....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
8

Impact of patient: donor HLA disparity on reduced-intensity..:

Loke, J. ; Labopin, M. ; Craddock, C....
Bone Marrow Transplantation.  56 (2020)  3 - p. 614-621 , 2020
Link: https://doi.org/10.1038/..
 
?
9

EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE ..:

Steinerova, K. ; Jindra, P. ; Lysak, D....
Hematological Oncology.  37 (2019)  S2 - p. 478-479 , 2019
Link: https://doi.org/10.1002/..
 
?
10

Comparison of the immunomodulatory effect of single MSC bat..:

Hejretová, L. ; Čedíková, M. ; Dolejšová, M....
Cell and Tissue Banking.  21 (2019)  1 - p. 119-129 , 2019
Link: https://doi.org/10.1007/..
 
?
11

Optimal Donor Selection During Verification Process: Which ..:

Houdová, L. ; Fetter, M. ; Jindra, P..
Transplantation Proceedings.  50 (2018)  10 - p. 3082-3087 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Association of HLA‐DRB1 and HLA‐DQB1 with red‐blood‐cell al..:

Maluskova, A. ; Mrazek, F. ; Pauliskova, M....
Vox Sanguinis.  112 (2017)  2 - p. 156-162 , 2017
Link: https://doi.org/10.1111/..
 
?
13

A novel HLA‐A null allele (A*02:395N) with stop codon in ex..:

Jindra, P. ; Venigová, P. ; Houdová, L..
Tissue Antigens.  81 (2013)  6 - p. 451-452 , 2013
Link: https://doi.org/10.1111/..
 
?
14

CD34+ cell content in unrelated allogeneic peripheral blood..:

Lysák, D. ; Merglová, L. ; Navrátilová, J....
Transfusion and Apheresis Science.  47 (2012)  2 - p. 179-184 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Detection of A B acute lymphoblastic leukaemia blast-specif..:

Venigová, P. ; Jindra, P. ; Koza, V.
International Journal of Immunogenetics.  38 (2011)  4 - p. 285-286 , 2011
Link: https://doi.org/10.1111/..
 
1-15